Groundbreaking Discovery: Common Heart Medicines May Reverse Fatty Liver Disease and Cut Heart Risks
Novo Nordisk Secures Future in Liver Disease, Acquires Akero Therapeutics in Landmark Deal
Unmasking the Sweet Threat: How Sugary Drinks Skyrocket Your Liver Disease Risk by 60%
The Silent Threat Within: How Common Fatty Liver Transforms into a Deadly Disease
Rezdiffra's Global Ascendancy: Madrigal Pharmaceuticals Reshaping NASH Treatment
Groundbreaking Trial: ION224 Shows Remarkable Promise in Combating MASH Liver Inflammation
Vitamin B3: A Groundbreaking, Affordable Hope in the Fight Against Fatty Liver Disease
A New Dawn for Liver Health: FDA Greenlights Revolutionary MASH Treatment